# Clinical Trial to Evaluate the PK Interactions of YHR2402 Monotherapy and YHR2402 and YHR2403 Co-Administration in Healthy Volunteers

> **NCT06623526** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 26 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** YHR2402
- **DRUG:** YHR2402+YHR2403

## Key facts

- **NCT ID:** NCT06623526
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-04
- **Primary completion:** 2024-11-06
- **Final completion:** 2024-11-11
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06623526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06623526, "Clinical Trial to Evaluate the PK Interactions of YHR2402 Monotherapy and YHR2402 and YHR2403 Co-Administration in Healthy Volunteers". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06623526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*